Oxford Biomedica plc New (OXBDF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 28 76 sessions, November 5, 2025 to November 5, 2026
- Largest daily move
- -17.9% close of March 2, 2026
- 1-year change
- -15.5% closing prices, November 5, 2025 to November 5, 2026
- 1-month change
- +2.6% closing prices, October 2, 2026 to November 5, 2026
Company Description
Oxford Biomedica plc New (OTC: OXBDF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $892.7M.
OXBDF has declined 15.5% over the past year. The last closing price was $7.35.
This page collects what Stock Titan holds for OXBDF, including price data and short interest trends.
Stock Performance
Oxford Biomedica plc New (OXBDF) closed at $7.35 on November 5, 2026. Over the past 12 months, the price has lost 15.5%.
OXBDF Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Short Interest History
Short interest in Oxford Biomedica plc New (OXBDF) currently stands at 242.9 thousand shares, down 0.5% from the previous reporting period, representing 0.3% of the float. Since November 2025, short interest has increased by 181.1%.
Days to Cover History
Days to cover for Oxford Biomedica plc New (OXBDF) currently stands at 75.9 days, up 173.6% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 2.6 to 353.0 days.
OXBDF Company Profile & Sector Positioning
Oxford Biomedica plc New (OXBDF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing OXBDF often look at related companies in the same sector, including Pharming Group NV (PHGUF), Nxera Pharma Co Ltd (SOLTF), Inventiva SA ACT Porteur (IVEVF), Pharma Mar SA New (PHMMF), and Silence Therapeutics (SLNCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OXBDF's relative position within its industry.